The role of Ki67 proliferation assessment in predicting local control in bladder cancer patients treated by radical radiation therapy (Q74533236)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

The role of Ki67 proliferation assessment in predicting local control in bladder cancer patients treated by radical radiation therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

P C Lara

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Rey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

C Santana

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J L Afonso

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J M Diaz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

G J González

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R Apolinario

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

Radiotherapy and Oncology

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

163-167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

A method to measure the duration of DNA synthesis and the potential doubling time from a single sample

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

The clinical status of Tpot as a predictor? or why no tempest in the Tpot!

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Clinical evidence for tumor clonogen regeneration: interpretations of the data.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

A pilot study of accelerated fractionation in the radiotherapy of invasive carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Cell kinetics and tumor regression during radiotherapy in head and neck squamous-cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Regression Models and Life-Tables (with discussion)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Radical Cystectomy without Radiation Therapy for Carcinoma of the Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Correlation of cervical carcinoma c-erb B-2 oncogene with cell proliferation parameters in patients treated with radiation therapy for cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Significance of downstaging in muscle-invasive bladder cancer treated with preoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

The decreased influence of overall treatment time on the response of human breast tumor xenografts following prolongation of the potential doubling time (Tpot)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Proliferative potential of brain tumors. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nuclear organizer region counts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Prognostic value of Ki-67 antigen and p53 protein in urinary bladder cancer: immunohistochemical analysis of radical cystectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900033-4

7 January 2021

10.1016/S0167-8140(98)00033-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10052882%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference